[1] Wen N,Cai Y, Li F, et al. The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines: 2022 update. Biosci Trends, 2022, 16(1):20-30. [2] 杜联江,李京涛,崔杰.肝细胞癌癌组织caspase-3和DcR3蛋白及SNHG12 mRNA水平变化及其临床意义探讨.实用肝脏病杂志,2022,25(5):706-709. [3] Molina-Sánchez P, Ruiz de Galarreta M, Yao MA, et al. Cooperation between distinct cancer driver genes underlies intertumor heterogeneity in hepatocellular carcinoma. Gastroenterology, 2020, 159(6):2203-2220. [4] Chen X, Zhao T,Ke N, et al. In-vitro differentiation of human embryonic stem cells into spinal cord neural stem cells. Neuroreport, 2022, 33(12):518-525. [5] Tang Y, Wang T, Yu Y, et al. Upregulation of HOXC9 generates interferon-gamma resistance in gastric cancer by inhibiting the DAPK1/RIG1/STAT1 axis. CancerSci, 2021, 112(9):3455-3468. [6] Li C, Feng C, Chen Y, et al. Arsenic trioxide induces the differentiation of retinoic acid-resistant neuroblastoma cells via upregulation of HoxC9.Adv Clin Exp Med, 2022, 31(8):903-911. [7] Bi R, Wei W, Lu Y, et al. High hsa_circ_0020123 expression indicates poor progression to non-small cell lung cancer by regulating the miR-495/HOXC9 axis. Aging (Albany NY), 2020, 12(17):17343-17352. [8] Song Y, Tang W, Li H. Identification of KIF4A and its effect on the progression of lung adenocarcinoma based on the bioinformatics analysis.Biosci Rep, 2021, 41(1):BSR20203973. [9] 陈丽娟,高学忠,曹茵,等.miR-379和人类驱动蛋白家族成员4A在三阴性乳腺癌中的表达及其关系.中国医师杂志,2022,24(7):1028-1031,1036. [10] 中华人民共和国卫生和计划生育委员会医政医管局.原发性肝癌诊疗规范(2017年版).中华消化外科杂志,2017,16(7):635-647. [11] Cai L, Wang Z, Zheng H, et al. The let-7c/HoxB7 axis regulates the cell proliferation, migration and apoptosis in hepatocellular carcinoma. Anticancer Drugs, 2020, 31(1):6-18. [12] 林海燕,王丽华,林红霞等.p53通路基因多态性与HBV感染相关肝细胞癌患者术后病毒激活的关联.中华医院感染学杂志,2022,32(10):1473-1477. [13] 王洪雨,范文哲,姚望,等.中性粒细胞与淋巴细胞比值在肝细胞癌预后中的应用现状.中华医学杂志,2020,100(25):1995-1998. [14] 戴维,戴嘉良,谭小宇,等.驱动蛋白家族20A和星形胶质细胞上调基因-1蛋白在肝癌组织的表达及其临床意义.中华实验外科杂志,2020,37(3):528-530. [15] Peng X, Kang Q, Wan R, et al. miR-26a/HOXC9 dysregulation promotes metastasis and stem cell-like phenotype of gastric cancer. CellPhysiol Biochem, 2018, 49(4):1659-1676. [16] Aguiar GM, Ramão A, Plaça JR, et al. Upregulation of HOX genes promotes cell migration and proliferation in head and neck squamous cell carcinoma. Tumour Biol, 2021, 43(1):263-278. [17] Zhao XF, Yang YS, Park YK. HOXC9 overexpression is associated with gastric cancer progression and a prognostic marker for poor survival in gastric cancer patients.Int J Clin Oncol, 2020, 25(12):2044-2054. [18] Cao YM, Wen D, Qu N, et al. Prognostic and clinical significance of HOXC9 and HOXD10 in papillary thyroid cancer.Transl Cancer Res, 2021, 10(7):3317-3325. [19] Matsushita J, Suzuki T, Okamura K, et al. Identification by TCGA database search of five genes that are aberrantly expressed and involved in hepatocellular carcinoma potentially via DNA methylation changes. Environ HealthPrev Med, 2020, 25(1):31. [20] Li X, Huang W, Huang W, et al. Kinesin family members KIF2C/4A/10/11/14/18B/20A/23 predict poor prognosis and promote cell proliferation in hepatocellular carcinoma. Am JTransl Res, 2020, 12(5):1614-1639. |